Medical News

Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer as per results of a large clinical trial of Avastin, an anti-angiogenic treatment. The study, reported in the December 27th issue of the New England Journal (NEJM), observed that Avastin in combination with chemotherapy significantly prolongs progression-free survival for women with breast cancer in comparison to chemotherapy alone……..

Original post by Health news from medicineworld.org

Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer as per results of a large clinical trial of Avastin, an anti-angiogenic treatment. The study, reported in the December 27th issue of the New England Journal (NEJM), observed that Avastin in combination with chemotherapy significantly prolongs progression-free survival for women with breast cancer in comparison to chemotherapy alone……..

Original post by Health news from medicineworld.org